Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > News tomorrow (surprise news)

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron May 04, 2023 1:32pm

146 Views

Post# 35430541

RE:News tomorrow (surprise news)

That is the fourth funniest post I have seen on this board: behind Noteable's - flocking-right - inthno's - dead cat bounce - (in relation to Schrodinger's cat not existing) - and my - taking the piss -(in relation to Pfizer).

This long journey needs a little humour and I always try and add a little in my posts.

Congratulations sweetie, but no medal.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec